ArticleJournal of experimental & clinical cancer research : CR2024

NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction.

Guozheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.